Targeted Oncology: Data Shows How Ruxolitinib is the Cornerstone of Treatment in Myelofibrosis Posted on September 12, 2022 at 11:13 am.Shared by contributor Ruben Mesa, MD, Mays Cancer Center, was interviewed for this article. Watch Video Share This Article!
